Advancing its commitment to patients and New Jersey, Novo Nordisk unveiled its new U.S. headquarters in April 2013. Located in Mercer County in Plainsboro, N.J., the 731,000-square-foot building is the result of a $225 million redevelopment project, which utilized an existing structure and sustainable materials to limit environmental impact. The public and private sectors collaborated on this redevelopment project, which created over 500 union construction jobs.
Oct 19, 2011
Lt. Governor Guadagno, Local Elected Officials, Business and Community Leaders Join Novo Nordisk, Ivy Equities, LCOR and Intercontinental RE Corp. to Celebrate Groundbreaking for Diabetes Leader’s New U.S. Headquarters
Leaders Mark Commencement of $215 Million Redevelopment Project to Retain Headquarters of Global Healthcare Company in New Jersey
Apr 19, 2013
Diabetes leader bolsters presence in N.J. with 731,000-square-foot office building in Plainsboro, N.J.